Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
September 15, 2021
[Peripheral Blood Inflammation Indicators as Predictive Indicators in Immunotherapy of Advanced Non-small Cell Lung Cancer]
Jingwei Xia, Yuzhong Chen, Shaodi Wen, et al.
Frontiers in Cell and Developmental Biology
|
February 1, 2024
Editorial: Single-cell and spatial-omics in delineating immune-related diseases
Shaodi Wen, Steven Mo, Jin Zhou, et al.
Critical Reviews in Oncology/Hematology
|
June 13, 2021
Efficacy and safety of first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) combined with chemotherapy or antiangiogenic therapy as first-line treatment in patients with EGFR-mutant non-small cell lung cancer: A systematic review and meta-analysis
Yuzhong Chen, Shaodi Wen, Yuan Wu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
March 21, 2025
[Exploration of the Predictive Value of Peripheral Blood-related Indicators for EGFR Mutations and Prognosis in Non-small Cell Lung Cancer Using Machine Learning]
Shulei Fu, Shaodi Wen, Jiaqiang Zhang, et al.
BMC Cancer
|
February 21, 2022
Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO
Shaodi Wen, Weiwei Peng, Yuzhong Chen, et al.
Frontiers in Immunology
|
June 24, 2021
Corrigendum: Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer
Yuzhong Chen, Shaodi Wen, Jingwei Xia, et al.
Frontiers in Immunology
|
May 31, 2021
Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer
Yuzhong Chen, Shaodi Wen, Jingwei Xia, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
November 26, 2025
FN-1501 Synergistically Enhances Almonertinib Efficacy in EGFR-TKI-Resistant Lung Adenocarcinoma through Ferroptosis Induction
Sitong Feng, Chen Peng, Dan Zou, et al.
Pharmacological Research
|
December 20, 2024
Targeting regulated cell death (RCD) with naturally derived sesquiterpene lactones in cancer therapy
Cong Xu, Shaodi Wen, Xiaoyue Du, et al.
Experimental Cell Research
|
November 11, 2022
Gastric cancer-derived mesenchymal stem cells promote gastric cancer cell lines migration by modulating CD276 expression
Qiuzhi Gao, Linjing Cui, Chao Huang, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
September 15, 2021
[Peripheral Blood Inflammation Indicators as Predictive Indicators in Immunotherapy of Advanced Non-small Cell Lung Cancer]
Jingwei Xia, Yuzhong Chen, Shaodi Wen, et al.
Frontiers in Cell and Developmental Biology
|
February 1, 2024
Editorial: Single-cell and spatial-omics in delineating immune-related diseases
Shaodi Wen, Steven Mo, Jin Zhou, et al.
Critical Reviews in Oncology/Hematology
|
June 13, 2021
Efficacy and safety of first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) combined with chemotherapy or antiangiogenic therapy as first-line treatment in patients with EGFR-mutant non-small cell lung cancer: A systematic review and meta-analysis
Yuzhong Chen, Shaodi Wen, Yuan Wu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
March 21, 2025
[Exploration of the Predictive Value of Peripheral Blood-related Indicators for EGFR Mutations and Prognosis in Non-small Cell Lung Cancer Using Machine Learning]
Shulei Fu, Shaodi Wen, Jiaqiang Zhang, et al.
BMC Cancer
|
February 21, 2022
Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO
Shaodi Wen, Weiwei Peng, Yuzhong Chen, et al.
Frontiers in Immunology
|
June 24, 2021
Corrigendum: Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer
Yuzhong Chen, Shaodi Wen, Jingwei Xia, et al.
Frontiers in Immunology
|
May 31, 2021
Association of Dynamic Changes in Peripheral Blood Indexes With Response to PD-1 Inhibitor-Based Combination Therapy and Survival Among Patients With Advanced Non-Small Cell Lung Cancer
Yuzhong Chen, Shaodi Wen, Jingwei Xia, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
November 26, 2025
FN-1501 Synergistically Enhances Almonertinib Efficacy in EGFR-TKI-Resistant Lung Adenocarcinoma through Ferroptosis Induction
Sitong Feng, Chen Peng, Dan Zou, et al.
Pharmacological Research
|
December 20, 2024
Targeting regulated cell death (RCD) with naturally derived sesquiterpene lactones in cancer therapy
Cong Xu, Shaodi Wen, Xiaoyue Du, et al.
Experimental Cell Research
|
November 11, 2022
Gastric cancer-derived mesenchymal stem cells promote gastric cancer cell lines migration by modulating CD276 expression
Qiuzhi Gao, Linjing Cui, Chao Huang, et al.
Page
of 3